Unrelated Donor Marrow Transplantation for Treatment of Childhood Hematologic Malignancies-Effect of HLA Disparity and Cell Dose

  • Ann E. Woolfrey
  • Claudio Anasetti
  • Effie W. Petersdorf
  • Paul J. Martin
  • Jean E. Sanders
  • John A. Hansen
Part of the Cancer Treatment and Research book series (CTAR, volume 101)


Marrow and hematopoietic cell transplants provide the possibility of a cure for patients with high risk and therapy-resistant leukemia. However the minority of patients are fortunate enough to have an HLA identical sibling. Transplants from HLA matched unrelated donors were of only theoretical interest given the very high degree of polymorphism among HLA antigens throughout the human population and the lack of organized groups of HLA-typed volunteer donors. Demonstration in the early 1980’s that unrelated marrow transplants were medically feasible gave great impetus to the creation of publicly supported donor registries (1-3). In the U.S., a national registry was authorized by congressional legislation in 1984, and in 1986 a federal contract initially administered by the Office of Naval Research was awarded to a consortium of investigators and centers headed by Dr. Jeffrey McCullough of the University of Minnesota (4). This consortium grew to become a comprehensive network of donor recruitment groups, donor centers, marrow and stem cell collection centers, and transplant centers known as the National Marrow Donor Program (NMDP). The NMDP currently consists of 96 donor centers and 127 transplant centers, including 8 donor centers located in countries outside the United States. National registries also exist in several other countries.


Acute Lymphoblastic Leukemia Marrow Transplantation Allogeneic Hematopoietic Stem Cell Transplantation Unrelated Donor Acute Myelogenous Leukemia Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980; 303: 565–567.PubMedCrossRefGoogle Scholar
  2. 2.
    McCullough J: Bone marrow transplantation from unrelated voluntary donors: summary of a conference on scientific, ethical, legal, financial and practical issues. Transfusion 1982; 22: 78.CrossRefGoogle Scholar
  3. 3.
    Cleaver S: The Anthony Nolan Research Centre and other matching registries. In: Treleaven and Barret (eds.) Bone Marrow Transplantation in Practice. Edinburgh, Churchill Livingston 1992; 361–366.Google Scholar
  4. 4.
    McCullough J, Hansen J, Perkins H, Stroncek D, Bartsch G: The National Marrow Donor Program: How it works, accomplishments to date. Oncology 1989;3: 63–74.PubMedGoogle Scholar
  5. 5.
    Oudshoorn M, Leeuwen A, Zanden HGMv, Rood JJv: Bone marrow donors worldwide: a successful exercise in international cooperation. Bone Marrow Transplant 1994; 14: 3–8.PubMedGoogle Scholar
  6. 6.
    Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf, EW, Appelbaum FR, Buckner CD, Matthews D, Storb R. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247–3256.PubMedGoogle Scholar
  7. 7.
    Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593–602.PubMedCrossRefGoogle Scholar
  8. 8.
    Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226–4235.PubMedGoogle Scholar
  9. 9.
    Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, Mickelson EM, Choo SY, Petersdorf EW, Pepe MS, Apelbaum FR, Bearman SI, Buckner CD, Clift RA, Petersen FB, Singer J, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP, Thomas ED: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249–253.PubMedGoogle Scholar
  10. 10.
    Slattery JT, Sanders JE, Buckner CD, Schaffer RL, Lambert KW, Langer, FP, Anasetti C, Bensinger WI, Fisher LD, Appelbaum FR. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995; 16: 31–42.PubMedGoogle Scholar
  11. 11.
    Terenzi A, Aversa F, Albi N, Galandrini R, Dembech C, Velardi A, et al. Residual clonable host cell detection for predicting engraftment of T cell depleted BMTs. Bone Marrow Transplant. 1993; 11: 357–361.6.PubMedGoogle Scholar
  12. 12.
    Santamaria P, Reinsmoen NL, Lindstom, AL, Boyce-Jacino, MT, Barbosa, JJ, Faras AJ, et al. Frequent Hla Class I and DP Sequence Mismatches in Serologically (HLA-A, HLA-B, HLA-DR) and Molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-Identical Unrelated Bone Marrow Transplant Pairs. Blood 1994; 83: 280–287.PubMedGoogle Scholar
  13. 13.
    Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818–1823.PubMedGoogle Scholar
  14. 14.
    Petersdorf, EW, Gooley TA, Anasetti C, Martin PJ, Mickelson E, Smith AG, Woolfrey AE, Hansen JA. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92(10): 3515–3520.PubMedGoogle Scholar
  15. 15.
    Anasetti C, Hansen JA. Bone marrow transplantation from HLA-partially matched related donors and unrelated volunteer donors. In: Forman SJ, Blume KG, Thomas ED, editors. Bone Marrow Transplantation. Boston, MA: Blackwell Scientific Publications, 1994: 665–680.Google Scholar
  16. 16.
    Anasetti C, Tan P, Hansen JA, Martin PJ. Induction of specific nonresponsiveness in unprimed human T cell byanti-CD3 antibody and alloantigen. J.Exp.Med. 1990; 172: 1691–1700.PubMedCrossRefGoogle Scholar
  17. 17.
    Bjerke JW, Lorenz J, Martin PJ, Storb R, Hansen JA, Anasetti C: Treatment of graft failure with anti-CD3 antibody BD3, glucocorticoids and infusion of donor hematopoietic cells. Blood 1995; 86: 107a.Google Scholar
  18. 18.
    Davies SM, Shu XO, Blazar BR, Filipovich AH, Kersey JH, Krivit W, McCullough J, Miller WJ, Ramsay NK, Segall M. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636–1642.PubMedGoogle Scholar
  19. 19.
    Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962–968.PubMedCrossRefGoogle Scholar
  20. 20.
    Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM, Pepe MS, Appelbaum FR, Buckner CD, Clift RA, Petersen FB, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443–447.PubMedCrossRefGoogle Scholar
  21. 21.
    Morton AJ, Anasetti C, Gooley T, Flowers M, Deeg HJ, Hansen JA, Martin PJ, Sullivan KM: Chronic graft versus host disease following unrelated donor transplantation (submitted).Google Scholar
  22. 22.
    Morton AJ, Gooley T, Hansen JA, Appelbaum FR, Bjerke JW, Clift R, Martin PJ, Petersdorf EW, Sanders JE, Storb R, Sullivan KM, Woolfrey A, Anasetti C. Association between pre-transplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood 1998; 92: 394–401.PubMedGoogle Scholar
  23. 23.
    Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, Hansen JA: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation Blood 1995; 86: 1606–1613.PubMedGoogle Scholar
  24. 24.
    Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Martin PJ, Hansen JA. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci USA 1996; 93: 15358–15363.PubMedCrossRefGoogle Scholar
  25. 25.
    Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, Yoshida T, Kimura A, Akaza T, Kamikawaji N, Kodera Y, Takaku F, for the JMDP: Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998;339: 1177–1185.PubMedCrossRefGoogle Scholar
  26. 26.
    Davies SM, Wagner JE, Shu XO, Blazar BR, Katsanis E, Orchard PJ, Kersey JH, Dusenbery KE, Weisdorf DJ, McGlave PB, Ramsay NK. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 1997; 15: 557–565.PubMedGoogle Scholar
  27. 27.
    Arnold R, deWitte T, vanBiezen A, Hermans J, Jacobsen N, Runde V, Gratwohl A, Apperley JF. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group. Bone Marrow Transplant 1998; 21: 1213–1216.PubMedCrossRefGoogle Scholar
  28. 28.
    Hongeng S, Krance RA, Bowman LC, Srivastava DK, Cunningham JM, Horwitz EM, Brenner MK, Heslop HE. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350: 767–771.PubMedCrossRefGoogle Scholar
  29. 29.
    Cornish JM, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A, Goulden P, Goulden N, Knechtli C, Hale G, Waldmann H, Oakhill A. Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion.Bone Marrow Transplant 1996; 18 Suppl 2: 31–35.PubMedGoogle Scholar
  30. 30.
    Oakhill A, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A, Goulden P, Goulden NJ, Hale G, Waldmann H, Cornish JM. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Brit J Haematol 1996;94: 574–578.CrossRefGoogle Scholar
  31. 31.
    Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM: Treatment of acute lymphoblastic leukemia. 30 years’ experience at St. Jude Children’s Research Hospital. N Eng J Med 1993; 329: 1289–1295.CrossRefGoogle Scholar
  32. 32.
    Ortega JJ, Olive T. Haematopoietic progenitor cell transplant in acute leukaemias in children: indications, results and controversies. Bone Marrow Transplant 1998; 21(Suppl 2): S11–S16.PubMedGoogle Scholar
  33. 33.
    Bordigoni P, Vernant JP, Souillet G, Gluckman E, Marininchi D, Milpied N, Fischer A, Benz LE, Jouet JP, Reiffers J. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: acooperative study of the Groupe d’Etude de la Greffe de Moelle Osseuse. Journal of Clinical Oncology 1989; 7: 747–753.PubMedGoogle Scholar
  34. 34.
    Stockschlader M, Hegewisch-Becker S, Kruger W, Dieck A tom, Mross K, Hoffknecht M, Berger C, Kohlschutter B, Martin H, Peters S. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1995; 16: 663–667.PubMedGoogle Scholar
  35. 35.
    Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O’Donnell MR, Schmidt GM, Stein AS: Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920–2928.PubMedGoogle Scholar
  36. 36.
    Sierra J, Radich J, Hansen JA, Martin PJ, Petersdorf EW, Bjerke J, Bryant E, Nash RA, Sanders JE, Storb R, Sullivan KM, Appelbaum FR, Anasetti C. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1997; 90: 1410–1414.PubMedGoogle Scholar
  37. 37.
    Marks DI, Bird JM, Cornish JM, Goulden NJ, Jones CG, Knechtli CJ, Pamphilon DH, Steward CG, Oakhill A. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 931–936.PubMedGoogle Scholar
  38. 38.
    Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, Ramsay NK. Autologous versus unrelateddonor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997; 90: 2962–2968.PubMedGoogle Scholar
  39. 39.
    Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan, GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331: 1253–1258.PubMedCrossRefGoogle Scholar
  40. 40.
    Chessels JM, Leiper AD, Richards SM: A second course of treatment for childhood acute lymphoblastic leukemia: long-term follow-up is needed to assess results. Brit J Haematol 1994; 86: 48–54.CrossRefGoogle Scholar
  41. 41.
    Henze G, Fengler R, Hartmann R, Niethammer D, Schellong G, Riehm H: BFM group treatment results in relapsed childhood acute lymphoblastic leukemia. Hamatologie Bluttransfusion 1990; 33: 619–626.CrossRefGoogle Scholar
  42. 42.
    Sanders JE, Flournoy N, Thomas ED, Buckner CD, Lum LG, Clift RA, Appelbaum FR, Sullivan KM, Stewart P, Deeg HJ, Doney K, Storb R: Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse and graft-versus-host disease. Med Pediatr Oncol 1985 13: 165–172.PubMedCrossRefGoogle Scholar
  43. 43.
    Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O’Reilly RJ: Allogeneic bone marrow transplantation after hyperfractionated total body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987; 317: 1618.PubMedCrossRefGoogle Scholar
  44. 44.
    Pinkel D: Bone marrow transplantation in children. J Pediatr 1993; 122: 331–341.PubMedCrossRefGoogle Scholar
  45. 45.
    Chessels JM, Rogers DW, Leiper AD, Blacklock H, Plowman PN, Richards S, Levinsky R, Festenstein H: Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia. Lancet 1986;1(8492): 1239–1241.CrossRefGoogle Scholar
  46. 46.
    Wheeler K, Richards S, Bailey C, Chessells J. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia. Brit J Haematol 1998; 101: 94–103.CrossRefGoogle Scholar
  47. 47.
    Greinix HT, Reiter E, Keil F, Fischer G, Lechner K, Dieckmann K, Leitner G, Schulenburg A, Hoecker P, Haas OA, Knoebl P, Mannhalter C, Fonatsch C, Hinterberger W, Kalhs P. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Bone MarrowTransplant 1998;21: 673–678.CrossRefGoogle Scholar
  48. 48.
    Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354–2363.PubMedGoogle Scholar
  49. 49.
    Weisdorf DJ: Bone marrow transplantation for acute lymphocytic leukemia (ALL). Leukemia 1997;11(4): S20–S22.PubMedGoogle Scholar
  50. 50.
    Wells RJ, Woods WG, Buckley JD, Odom LF, Benjamin D, Bernstein I, Betcher D, Feig S, Kim T, Ruymann F: Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study. J.Clin.Oncol 1994; 12: 2367–2377.PubMedGoogle Scholar
  51. 51.
    Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, Barnard D, Benjamin D, DeSwarte J, Kalousek D, Shina D, Hammond GD, Lange BJ: Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J.Clin.Oncol 1993; 11: 1448.PubMedGoogle Scholar
  52. 52.
    Woods WG, Kobrinsky N, Buckley J, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Dusenbery K, Kalousek D, Arthur DC, Lange BJ: Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children’s Cancer Group. Blood 1996; 87: 4979–4989.PubMedGoogle Scholar
  53. 53.
    Amadori S, Testi AM, Arico M, Comelli A, Giuliano M, Madon E, Masera G, Rondelli R, Zanesco L, Mandelli F: Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol. 1993; 11: 1046–1054.PubMedGoogle Scholar
  54. 54.
    Stevens RF, Hann IM, Wheatley K, Gray RG. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council’s 10th AML trial. MRC Childhood Leukaemia Working Party. British Journal of Haematology 1998; 101: 130–140.PubMedCrossRefGoogle Scholar
  55. 55.
    Gift RA, Buckner CD, Appelbaum FR, Schoch G, Petersen FB, Bensinger WI, Sanders J, Sullivan KM, Storb R, Singer J, Hansen JA, Thomas ED: Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 1992; 10: 1723.Google Scholar
  56. 56.
    Chown SR, Marks DI, Cornish JM, Pamphilon DH, Potter MN, Steward CG, Oakhill A. Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission. British Journal of Haematology 1997; 99: 36–40.PubMedCrossRefGoogle Scholar
  57. 57.
    Woolfrey AE, Gooley TA, Sievers EL, Mulner LA, Andrews RG, Walters M, Hoffmeister P, Hansen JA, Anasetti C, Bryant E, Appelbaum FR, Sanders JE: Bone marrow transplantation for children less than two years of age with acute myelogenous leukemia or myelodysplastic syndrome. Blood, 1998;92: 3546–3556.PubMedGoogle Scholar
  58. 58.
    Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED: Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 1983; 61: 949–953.PubMedGoogle Scholar
  59. 59.
    Gale RP, Horowitz MM, Rees JK, Gray RG, Oken MM, Estey EH, Kim KM, Zhang MJ, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PS, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HG, Reiffers J, Rimm AA, Bortin MM. Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 1996; 10: 13–19.PubMedGoogle Scholar
  60. 60.
    Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, Mickelson EM, Choo SY, Petersdorf EW, Pepe MS: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249–253.PubMedGoogle Scholar
  61. 61.
    Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990; 322: 485–494.PubMedCrossRefGoogle Scholar
  62. 62.
    Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Brock Jacobsen B: Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 1996;10: 1269–1273.PubMedGoogle Scholar
  63. 63.
    Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ: Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73: 619–622.PubMedGoogle Scholar
  64. 64.
    Locatelli F, Niemeyer C, Angelucci E, Bender-Gotze C, Burdach S, Ebell W, Friedrich W, Hasle H, Hermann J, Jacobsen N, Klingebiel T, Kremens B, Mann G, Pession A, Peters C, Schmid HJ, Stary J, Suttorp, Uderzo C, van’t Veer-Korthof ET, Vossen J, Zecca M, Zimmermann M. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. Journal of Clinical Oncology 1997; 15: 566–573.PubMedGoogle Scholar
  65. 65.
    Anderson JE, Appelbaum FR, Fisher LD, Schoch G, Shulman H, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Doney K: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677–681.PubMedGoogle Scholar
  66. 66.
    Appelbaum FR, Storb R, Ramberg RE, Shulman HM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Sanders J, Stewart P: Allogeneic marrow transplantation in the treatment of preleukemia. Ann Intern Med 1984; 100: 689–693.PubMedGoogle Scholar
  67. 67.
    Anderson JE, Anasetti C, Appelbaum FR, Schoch G, Gooley TA, Hansen, JA, Buckner CD, Sanders JE, Sullivan KM, Storb R. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.British Journal of Haematology 1996; 93: 59–67.PubMedCrossRefGoogle Scholar
  68. 68.
    Frangoul HA, Gooley TA, Sanders JE: Allogeneic bone marrow transplantation (BMT) in children with de novo myelodysplastic syndrome (MDS). (Abstract) Blood (in press).Google Scholar
  69. 69.
    Davies SM, Wagner JE, Defor T, Blazar BR, Katsanis E, Kersey JH, Orchard PJ, McGlave PB, Weisdorf DJ, Ramsay NK. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. British Journal of Haematology 1997; 96: 749–756.PubMedCrossRefGoogle Scholar
  70. 70.
    Locatelli F, Giorgiani G, Comoli P. Allogeneic transplantation of haematopoietic progenitors for myelodysplastic syndromes and myeloproliferative disorders. Bone Marrow Transplant 1998; 21 Suppl 2: S17–S20.PubMedGoogle Scholar
  71. 71.
    Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd RL, Homans A, Chaffee S, Nitschke R, Gualtieri RJ. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia [see comments]. New England Journal of Medicine 1994; 331: 1680–1684.PubMedCrossRefGoogle Scholar
  72. 72.
    Sanders JE, Buckner CD, Thomas ED, Fleischer R, Sullivan KM, Appelbaum FA, Storb R. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988; 71: 1144–1146.PubMedGoogle Scholar
  73. 73.
    Chown SR, Potter MN, Cornish J, Goulden P, Goulden N, Pamphilon D, Steward CG, Oakhill AO. Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia. Brit J Haematol 1996; 93: 674–676.CrossRefGoogle Scholar
  74. 74.
    Locatelli F, Pession A, Comoli P, Bonetti F, Giorgiani G, Zecca M, Taibi RM, Mongini ME, Ambroselli F, de SP, Severi F, Paolucci. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia. British Journal of Haematology 1996; 92: 49–54.PubMedCrossRefGoogle Scholar
  75. 75.
    Bunin NJ, Casper JT, Lawton C, Murray K, Camitta BM, Greenwood M, Geil J, Ash RC. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bone Marrow Transplantation 1992; 9: 119–122.PubMedGoogle Scholar
  76. 76.
    Donadieu J, Stephan JL, Blanche S, Cavazzana-Calvo M, Baruchel A, Herbelin C, Benkerrou M, Thomas C, Girault D, Fischer A. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation [see comments]. Bone Marrow Transplantation 1994; 13: 777–782.PubMedGoogle Scholar
  77. 77.
    Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA: Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036–2043.PubMedGoogle Scholar
  78. 78.
    Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukaemia in chronic phase: a comparison of transplant versus no-transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986. Brit J Haematol 1993; 85: 292–299.CrossRefGoogle Scholar
  79. 79.
    Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. The. N Engl J Med 1994; 330: 820–825.CrossRefGoogle Scholar
  80. 80.
    Tura S, Rosti G, Devivo A, Bonifazi F, Fiacchini M, Baccarani M, Russo D, Fanin R, Zuffa E, Montefusco E: Long-term follow-up of the Italian trial of interferon-alpha versus conventional chemotherapy in chronic myeloid leukemia. Blood 1998; 92: 1541–1548.Google Scholar
  81. 81.
    Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. Blood 1998; 91: 1810–1819.PubMedGoogle Scholar
  82. 82.
    Marks DI, Cullis JO, Ward KN, Lacey S, Syzdlo R, Hughes TP, Schwarer, AP, Lutz E, Barrett AJ, Hows JM. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Int Med 1993; 119: 207–214.PubMedGoogle Scholar
  83. 83.
    Dini G, Lamparelli T, Rondelli R, Lanino E, Barbanti M, Costa C, Manfredini L, Guidi S, Rosti G, Alessandrino EP, Locatelli F, Marenco, Soligo D, Di BP, Aversa F, La NG, Busca A, Majolino, De LA, Bacigalupo A. Unrelated donor marrow transplantation for chronic myelogenous leukaemia. Brit J Haematol 1998; 102: 544–552.CrossRefGoogle Scholar
  84. 84.
    Dini G, Rondelli R, Miano M, Vossen J, Gluckman E, Peters C, Bordigoni P, Locatelli F, Miniero R, Ljungman P, Saarinen U, Klingebiel T, Ortega J, Lanino E: Unrelated donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 1996; 18: 80–85.PubMedGoogle Scholar
  85. 85.
    Gamis AS, Haake R, McGlave P, Ramsay NK. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. Journal of Clinical Oncology 1993; 11: 834–838.PubMedGoogle Scholar
  86. 86.
    Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Annals of Internal Medicine 1997; 127: 1080–1088.PubMedGoogle Scholar
  87. 87.
    McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan NA. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543–550.PubMedGoogle Scholar
  88. 88.
    Beelen DW, Graeven U, Elmaagacli AH, Niederle N, Kloke O, Opalka B, Schaefer UW. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 1995; 85: 2981–2990.PubMedGoogle Scholar
  89. 89.
    Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261–1268.PubMedGoogle Scholar
  90. 90.
    Radich JP, Sanders JE, Buckern CD, Martin PJ, Peterson FB, Bensinger W, McDonald, GB, Mori M, Schoch G, Hansen JA: Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant withtotal-body irradiation containing regimens. J Clin Oncol 1993; 11: 304–313.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Ann E. Woolfrey
    • 1
  • Claudio Anasetti
    • 1
  • Effie W. Petersdorf
    • 1
  • Paul J. Martin
    • 1
  • Jean E. Sanders
    • 1
  • John A. Hansen
    • 1
  1. 1.Fred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations